Cargando…
BCG re-vaccination in Malawi: 30-year follow-up of a large, randomised, double-blind, placebo-controlled trial
BACKGROUND: A large, double-blind, randomised, placebo-controlled trial of repeat BCG found 49% efficacy against leprosy but no protection against tuberculosis after 6–9 years’ follow-up in 1995. We report here additional follow-up, which resulted in greatly increased tuberculosis case numbers, and...
Autores principales: | Glynn, Judith R, Fielding, Katherine, Mzembe, Themba, Sichali, Lifted, Banda, Louis, McLean, Estelle, Kanjala, Chifundo, Crampin, Amelia C, Ponnighaus, Jorg M, Warndorff, David K, Fine, Paul E M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459381/ https://www.ncbi.nlm.nih.gov/pubmed/34534489 http://dx.doi.org/10.1016/S2214-109X(21)00309-0 |
Ejemplares similares
-
The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi
por: Glynn, Judith R, et al.
Publicado: (2021) -
Contribution of remote M.tuberculosis infection to tuberculosis disease: A 30-year population study
por: Glynn, Judith R., et al.
Publicado: (2023) -
Risk of Mycobacterium tuberculosis transmission in an antiretroviral therapy clinic
por: Mzembe, Themba, et al.
Publicado: (2018) -
Bayesian reconstruction of Mycobacterium tuberculosis transmission networks in a high incidence area over two decades in Malawi reveals associated risk factors and genomic variants
por: Sobkowiak, Benjamin, et al.
Publicado: (2020) -
Whole Genome Sequencing Shows a Low Proportion of Tuberculosis Disease Is Attributable to Known Close Contacts in Rural Malawi
por: Glynn, Judith R., et al.
Publicado: (2015)